A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.

Source:http://linkedlifedata.com/resource/pubmed/id/9916695

J. Immunol. 1999 Jan 15 162 2 753-60

Download in:

View as

General Info

PMID
9916695